Qi Wang

Qi Wang

Auto-generated profile, based on publicly available information

Qi Wang

Center for Reproduction and Genetic, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Chemical Engineering Journal
Verified
Journal Article
Closed access
MZMinyi Zhang
Minyi Zhang
XLXi-Jian Liu
Xi-Jian Liu
QLQian Luo
Qian Luo
QWQi Wang
Qi Wang
LZLinjing Zhao
Linjing Zhao
JLJie Lu
Jie Lu

1 April 2019 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
XZXiaofan Zeng
Xiaofan Zeng
QWQi Wang
Qi Wang
XTXuan Tan
Xuan Tan
LJLe Jia
Le Jia
YLYuwei Li
Yuwei Li
XYXiangliang Yang
Xiangliang Yang
Glioma is a common brain tumor with a high mortality rate. A small population of cells expressing stem-like cell markers in glioma contributes to drug resistance and tumor recurrence. Porous silicon nanoparticles (PSi NPs) as photothermal therapy (PTT) agents loaded with TMZ (TMZ/PSi NPs), was combined with hyperbaric oxygen (HBO) therapy in vitro and in vivo. To further investigate underlying mechanism, we detected the expression of stem-like cell markers and hypoxia related molecules in vitro and in vivo after treatment of TMZ/PSi NPs in combination with PTT and HBO. NCH-421K and C6 cells were more sensitive to the combination treatment. Moreover, the expression of stem-like cell markers and hypoxia related molecules were decreased after combination treatment. The in vivo results were in line with in vitro. The combination treatment presents significant antitumor effects in mice bearing C6 tumor compared with the treatment of TMZ, PTT or TMZ/PSi NPs only. These results suggested the TMZ/PSi NPs combined with HBO and PTT could be a potential therapeutic strategy for glioma.

1 October 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
XLXi Li
Xi Li
QWQi Wang
Qi Wang
GDGuoying Deng
Guoying Deng
YLYinping Liu
Yinping Liu
BWBoxuan Wei
Boxuan Wei
SWSufang Wu
Sufang Wu

27 November 2020 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
BWBenjing Wang
Benjing Wang
QZQin Zhang
Qin Zhang
QWQi Wang
Qi Wang
JMJun Ma
Jun Ma
XCXiaoju Cao
Xiaoju Cao
TWting wang
ting wang
The changes of metabolite profiles in preterm birth have been demonstrated using newborn screening data. However, little is known about the holistic metabolic model in preterm neonates. The aim was to investigate the holistic metabolic model in preterm neonates. All metabolite values were obtained from a cohort data of routine newborn screening. A total of 261 758 newborns were recruited and randomly divided into a training subset and a testing subset. Using the training subset, 949 variates were considered to establish a logistic regression model for identifying preterm birth (80% accuracy in both the training and testing subsets. When identifying neonates ≤32 weeks from those >32 weeks, it had a robust performance with nearly 95% accuracy in both subsets. In summary, we have established an excellent metabolic model in preterm neonates. These findings could provide new insights for more efficient nutrient supplements and etiology of preterm birth. # These authors contributed equally to this work. Received: 14 July 2020 Accepted: 20 October 2020 Publication Date: 27 November 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany